Skip to main content
Premium Trial:

Request an Annual Quote

EU s Newmood Project Launched at HUGO

NEW YORK, April 7 (GenomeWeb News) –  The European Union’s Newmood project launched this week at the Human Genome meeting in Berlin, Germany, according to news reports.

Newmood is a five-year project funded under the EC’s 6th Framework with  €7.3 million ($8.3M US) bringing together 13 laboratories over 10 countries to investigate the genetics of depression with the aim of developing new drug targets and to aid in the diagnosis.

According to a report published online today by Nature , researchers in the project will build an array of 800 genes that may be related to depression, including those affecting metabolism, growth and cell communication. The chip will detect which genes are active in healthy and depressed animals and humans.

Bill Deakin of the Neuroscience and Psychiatry unit of Manchester University (UK) is the project coordinator.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more